Skip to Content

Hot Startup Theranos Has Struggled with Its Blood-Test Technology
An investigative report by the Wall Street Journal questioning Theranos’s technology.
Antonio Regalado, senior editor, biomedicine

Four Reasons Drugs Are Expensive, of Which Two Are False
Forbes explores why drugs are so expensive.
—Antonio Regalado

Alzheimer’s Research Effort Is Ensnared in Legal Dispute
What happens when one university lifts a research team from another.
—Antonio Regalado

Raiders of the Lost Web
Coming to grips with how much stuff vanishes from the Web.
Brian Bergstein, executive editor

The Soul of the Human Machine
A commonsense way of thinking about the future of AI.
—Brian Bergstein

If You’re Not Paranoid, You’re Crazy
The cover story in this month’s Atlantic gets all twitchy about the extent to which we let ourselves be tracked and quantified nowadays.
Will Knight, senior editor, AI

Doppelgänger
An amusing and oddly revealing meeting between Apple cofounder Steve (“Woz”) Wozniak and Seth Rogen, who plays him in a new film.
—Will Knight

Keep Reading

Most Popular

This startup wants to copy you into an embryo for organ harvesting

With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.

VR is as good as psychedelics at helping people reach transcendence

On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.

This nanoparticle could be the key to a universal covid vaccine

Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.